The forecast for genitourinary system diseases mortality in Japan from 2024 through 2028 remains constant at 16.4 deaths per hundred thousand persons, standardized rates. Compared to previous actual data up to 2023, this rate does not indicate any year-on-year variation. The consistency signified in the forecast suggests a steady trend without significant increases or decreases expected over this period. The lack of change results in a zero compound annual growth rate (CAGR) for five years.

Future trends to watch for include:

Potential advancements in medical technologies and therapies that could impact mortality rates.
Demographic shifts such as aging population which might alter disease prevalence and outcomes.
Changes in healthcare policies that may affect treatment availability and disease management strategies.